Date published: 2026-2-6

1-800-457-3801

SCBT Portrait Logo
Seach Input

HSV-1 gE Envelope Protein Antibody (9H3): sc-56983

2.0(1)
Write a reviewAsk a question

Datasheets
  • HSV-1 gE Envelope Protein Antibody (9H3) is a mouse monoclonal IgG2a HSV-1 gE Envelope Protein antibody provided at 100 µg/ml
  • raised against herpes simplex virus type 1
  • recommended for detection of HSV-1 gE Envelope Protein by IF
  • At present, we have not yet completed the identification of the preferred secondary detection reagent(s) for HSV-1 gE Envelope Protein Antibody (9H3). This work is in progress.
    Crispr Promo Banner

    QUICK LINKS

    SEE ALSO...

    HSV-1 gE Envelope Protein Antibody (9H3) is a mouse monoclonal IgG2a antibody that detects HSV-1 gE Envelope Protein in human and mouse samples by immunofluorescence (IF). Anti-HSV-1 gE Envelope Protein antibody (9H3) is available as a non-conjugated format for research applications. HSV-1 gE Envelope Protein plays a vital role in viral entry by facilitating fusion between viral envelope and host cell membrane, enabling viral genome delivery into host cell cytoplasm. This fusion process is essential for establishing infection and viral replication. Understanding glycoprotein E function remains crucial for developing therapeutic strategies against herpes simplex virus infections, as targeting this protein could prevent host cell infection. HSV-1 gE Envelope Protein monoclonal antibody (9H3) serves as a valuable tool for researchers studying viral entry mechanisms, pathogenesis, and potential vaccine or antiviral therapy development.

    For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.

    Alexa Fluor® is a trademark of Molecular Probes Inc., OR., USA

    LI-COR® and Odyssey® are registered trademarks of LI-COR Biosciences

    HSV-1 gE Envelope Protein Antibody (9H3) References:

    1. Herpes simplex virus type 2 (HSV-2) infection in women attending an antenatal clinic in the South Pacific island nation of Vanuatu.  |  Haddow, LJ., et al. 2007. Sex Transm Dis. 34: 258-61. PMID: 16940899
    2. The microenvironment of vulvar skin in women with symptomatic and asymptomatic herpes simplex virus type 2 (HSV-2) infection.  |  Löwhagen, GB., et al. 2006. J Eur Acad Dermatol Venereol. 20: 1086-9. PMID: 16987263
    3. Development and validation of a capillary electrophoresis method for the characterization of herpes simplex virus type 1 (HSV-1) thymidine kinase substrates and inhibitors.  |  Iqbal, J., et al. 2007. J Chromatogr B Analyt Technol Biomed Life Sci. 846: 281-90. PMID: 17023224
    4. The HSV-2 protein ICP10PK prevents neuronal apoptosis and loss of function in an in vivo model of neurodegeneration associated with glutamate excitotoxicity.  |  Golembewski, EK., et al. 2007. Exp Neurol. 203: 381-93. PMID: 17046754
    5. Association between HSV-2 and HIV-1 viral load in semen, cervico-vaginal secretions and genital ulcers of Thai men and women.  |  Chu, K., et al. 2006. Int J STD AIDS. 17: 681-6. PMID: 17059638
    6. HSV infection and immunosuppression.  |  Sindhi, R. 2006. Liver Transpl. 12: 1906-7. PMID: 17133569
    7. Sulfasalazine unveils a contact-independent HSV-TK/ganciclovir gene therapy bystander effect in malignant gliomas.  |  Robe, PA., et al. 2007. Int J Oncol. 30: 283-90. PMID: 17143539
    8. Herpes simplex virus type 2 (HSV-2) establishes latent infection in a different population of ganglionic neurons than HSV-1: role of latency-associated transcripts.  |  Margolis, TP., et al. 2007. J Virol. 81: 1872-8. PMID: 17151134
    9. HSV-2- and HIV-1- permissive cell lines co-infected by HSV-2 and HIV-1 co-replicate HSV-2 and HIV-1 without production of HSV-2/HIV-1 pseudotype particles.  |  Legoff, J., et al. 2007. Virol J. 4: 2. PMID: 17207276

    Ordering Information

    Product NameCatalog #UNITPriceQtyFAVORITES

    HSV-1 gE Envelope Protein Antibody (9H3)

    sc-56983
    100 µg/ml
    $322.00